Patents Assigned to TransForm Phamaceuticals, Inc.
  • Publication number: 20060223794
    Abstract: The invention provides novel soluble olanzapine forms. These forms include salts, co-crystals, and solvates of olanzapine. The invention also provides novel pharmaceutical compositions comprising these novel soluble forms and related methods of treatment. Compositions and methods of the invention of the invention are useful in the treatment of psychosis and functional bowel disorders.
    Type: Application
    Filed: March 31, 2004
    Publication date: October 5, 2006
    Applicant: TransForm Phamaceuticals, Inc.
    Inventors: Magali Bourghol Hickey, Julius Remenar